| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/07/2001 | EP1150643A2 Microemulsion containing alkano lammonium salts of fatty alcohol sulfates and/or alkylpoly alkylene glykol ether sulfates |
| 11/07/2001 | EP1150630A1 Prolonged release bioadhesive vaginal gel dosage form |
| 11/07/2001 | EP1150629A1 Drug dosage unit for buccal administration of steroidal active agents |
| 11/07/2001 | EP1089620A4 Hydrophilic polymer blends used to prevent cow skin infections |
| 11/07/2001 | EP1003711B1 Novel lipopolyamines, and the preparation and use thereof |
| 11/07/2001 | EP0921812B1 Insulin preparations containing a halogenide |
| 11/07/2001 | EP0836475B1 Controlled release formulations for poorly soluble drugs |
| 11/07/2001 | EP0833609B1 Compositions and methods for stabilizing polymers |
| 11/07/2001 | EP0828477B1 Osmotic device with high drug loading and delayed activation of drug delivery |
| 11/07/2001 | EP0825865B1 Transdermal therapeutic system for administering testosterone |
| 11/07/2001 | EP0804161B1 Continuous method of grinding pharmaceutical substances |
| 11/07/2001 | EP0797429B1 Osmotic device for the continuous release of active substances into the fluids of the gastro-intestinal tract |
| 11/07/2001 | EP0776195B1 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
| 11/07/2001 | EP0751789B1 Gel for treatment of skin diseases and for disinfection of the skin |
| 11/07/2001 | EP0725628B1 Thermally-gelling drug delivery vehicles containing cellulose ethers |
| 11/07/2001 | EP0676935B1 Angiogenic tissue implant systems |
| 11/07/2001 | EP0659072B1 Pharmaceutical emulsions containing bioactive steroids |
| 11/07/2001 | EP0636033B1 Process for producing active agent complexes |
| 11/07/2001 | CN1321177A Modified starch film compositions |
| 11/07/2001 | CN1321165A Prevention and treatment of viral disease |
| 11/07/2001 | CN1321149A New crystal modification III of torasemide |
| 11/07/2001 | CN1321092A Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents |
| 11/07/2001 | CN1321090A Treatment of vascular restenosis |
| 11/07/2001 | CN1321088A sustained release ranolazine formulations |
| 11/07/2001 | CN1321086A Mucosal originated drug delivery system and animal applications |
| 11/07/2001 | CN1321085A Enteric and colonic delivery using HPMC capsules |
| 11/07/2001 | CN1321084A Pharmaceutical compositions comprising ibuprofen and domperidone |
| 11/07/2001 | CN1321083A Method for making coated gabapentine or pregabaline particles |
| 11/07/2001 | CN1321082A Micronised pharmaceutical compositions |
| 11/07/2001 | CN1321080A Fast dissolving orally consumable films |
| 11/07/2001 | CN1320451A Exterior-applied medicine for treating gynopathy |
| 11/07/2001 | CN1320445A Chinese-medicinal pill for treating rheumatoid arthritis |
| 11/07/2001 | CN1320443A Face-beautifying chewing gum and its preparing process |
| 11/07/2001 | CN1320442A Medicine for treating rheumatisms |
| 11/07/2001 | CN1320437A Chinese-medicinal herbs cigarette |
| 11/07/2001 | CN1320422A Process for preparing Chinese-medicinal pills containing borneol |
| 11/07/2001 | CN1320421A Freeze dried preparation of bacteriophagic Bdellovibrio and its preparing process |
| 11/07/2001 | CN1320420A Nm medicine and percutaneous administration system of its composition |
| 11/07/2001 | CN1074411C Method for preparing medicinal composition in noval physical form contg. heterocyclic amide deriv. |
| 11/07/2001 | CN1074295C 'Sanfengkangai' capsule for treating lung cancer and its preparing process |
| 11/07/2001 | CN1074292C Cancer treating medicine capsule |
| 11/07/2001 | CN1074290C Medicine for treating facial paralysis and its preparing method |
| 11/07/2001 | CN1074288C Preparation for stopping smoking and its preparing method |
| 11/07/2001 | CN1074286C Exterior-applied powder medicine for treating rheumatism and rheumatoid diseases and its preparing process |
| 11/07/2001 | CN1074282C Burn and scald ointment |
| 11/07/2001 | CN1074281C Chinese patent medicine for treatment of cerebral thrombus disease and thrombophlebitis, and preparation method thereof |
| 11/07/2001 | CN1074279C Estradiol benzoate gel agent and its preparing method |
| 11/07/2001 | CN1074278C Process for producing sterile freeze-dried prostaglandin E1 powder injection |
| 11/06/2001 | US6313370 Medicated wrap |
| 11/06/2001 | US6313103 Pectic substance as a growth factor stabilizer |
| 11/06/2001 | US6313102 Stabilized dry composition comprising therapeutic agent susceptible to maillard reaction, further comprising reducing carbohydrate as stabilizer for therapeutic agent and inhibitor of maillard reaction |
| 11/06/2001 | US6313093 Applying pharmaceutical composition comprising insulin to upper third of nasal cavity of mammal, wherein insulin is absorbed through nasal mucosa and transported to brain of mammal |
| 11/06/2001 | US6313092 Method for increasing the electrotransport flux of polypeptides |
| 11/06/2001 | US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers |
| 11/06/2001 | US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases |
| 11/06/2001 | US6312732 Biodegradable targetable microparticle delivery system |
| 11/06/2001 | US6312731 Polymer and swelling |
| 11/06/2001 | US6312730 Gum acacia, mixing powdered psyllium husks and drying |
| 11/06/2001 | US6312728 Drug delivery device with core, enteric polymer and coating |
| 11/06/2001 | US6312726 Acid resistant molding for sustained release drug |
| 11/06/2001 | US6312724 Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof |
| 11/06/2001 | US6312723 Compounds used in inhibiting gastric acid secretion 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole in tablet or capsule form with cyclodextrin |
| 11/06/2001 | US6312721 Drugs with carriers of esters of triglycerol with fatty acid and partial esters of decaglycerol and fatty acids |
| 11/06/2001 | US6312720 Liposomal recombinant human superoxide-dismutase for the treatment of peyronie's disease |
| 11/06/2001 | US6312719 Injections of unilamellar liposomes with phosphatides |
| 11/06/2001 | US6312718 Liposomal composition, b-cell malignancy antigen and lipids |
| 11/06/2001 | US6312717 Antidepressants or anti anxiety by administering azapirone and 5-ht1a autosomal receptor antagonist |
| 11/06/2001 | US6312716 Patch and method for transdermal delivery of bupropion base |
| 11/06/2001 | US6312715 Adhesive microsphere drug delivery composition |
| 11/06/2001 | US6312713 Polymer matrices for storage and sustained release of drugs and chemicals |
| 11/06/2001 | US6312712 Benzimidazole and cyclodextrin for gastric acid related diseases |
| 11/06/2001 | US6312708 Botulinum toxin implant |
| 11/06/2001 | US6312705 Complexes of iodine with nylon |
| 11/06/2001 | US6312704 Orally administrable composition capable of providing enhanced bioavailability when ingested |
| 11/06/2001 | US6312703 Drugs or cosmetics, liquid crystal solids and lecithin |
| 11/06/2001 | US6312665 Aerosol formulations for buccal and pulmonary application |
| 11/06/2001 | CA2250251C Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 11/01/2001 | WO2001081516A1 Oil-containing granular composition and method for producing the same |
| 11/01/2001 | WO2001081437A1 Low peak exotherm curable compositions |
| 11/01/2001 | WO2001081182A2 Improved method and apparatus for generating an aerosol |
| 11/01/2001 | WO2001080989A1 Transparent liquid composition |
| 11/01/2001 | WO2001080937A1 Drug delivery device for insertion in the vagina, rectum or nasal cavity |
| 11/01/2001 | WO2001080920A2 Antimicrobial bioabsorbable materials |
| 11/01/2001 | WO2001080902A2 A particulate complex for administering nucleic acid into a cell |
| 11/01/2001 | WO2001080900A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane |
| 11/01/2001 | WO2001080897A2 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics |
| 11/01/2001 | WO2001080889A1 Product and process for regulation of t cell responses |
| 11/01/2001 | WO2001080869A1 Minari extract for preventing the induction and metastasis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks |
| 11/01/2001 | WO2001080859A1 Transdermal therapeutic systems for applying moxonidine |
| 11/01/2001 | WO2001080858A1 Stable liquid preparation |
| 11/01/2001 | WO2001080852A1 Compositions and therapies for hyperlipidaemia-associated disorders |
| 11/01/2001 | WO2001080850A1 Urea-containing gel preparation |
| 11/01/2001 | WO2001080844A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 11/01/2001 | WO2001080840A2 Cytotoxic agents comprising single-stranded and/or looped dna |
| 11/01/2001 | WO2001080836A1 Use of particulate vectors in immunomodulation |
| 11/01/2001 | WO2001080835A1 Process for producing microsphere |
| 11/01/2001 | WO2001080834A1 Composition |
| 11/01/2001 | WO2001080833A1 Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 11/01/2001 | WO2001080832A2 Administration of a thiol-based chemoprotectant compound |
| 11/01/2001 | WO2001080831A2 Zero order release and temperature-controlled microcapsules and process for the preparation thereof |